LMP744 hydrochloride NEW
| Price | $122 | $239 | $372 |
| Package | 1mg | 5mg | 10mg |
| Supply Ability: | 10g |
| Update Time: | 2026-07-06 |
Product Details
| Product Name: LMP744 hydrochloride | CAS No.: 308246-57-3 |
| Purity: 99.85% | Supply Ability: 10g |
| Release date: 2026/07/06 |
Product Introduction
Bioactivity
| Name | LMP744 hydrochloride |
| Description | LMP744 hydrochloride (NSC-706744 hydrochloride) is a DNA intercalator and Topoisomerase I (Top1) inhibitor with antitumor activity.? |
| In vitro | LMP744 (0.1-5 μM, 3 days) induces dose-dependent accumulation of cells in the S and G2 phases of the cell cycle[2].The GI50 value of LMP744 for NCI60 cells is 0.1 μM[2]. |
| In vivo | LMP744 ?(10-50 mg/kg) administered i.v. push once a week for 4 weeks in nude mice moderately actives against human A253 and FaDu tumor xenografts without significant toxicity[1]. |
| Storage | Keep away from direct sunlight Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO : 5.56 mg/mL (11.37 mM), Sonication is recommended. |
| Keywords | Topoisomerase | Topo I | Top1 | NSC-706744 Hydrochloride | NSC706744 Hydrochloride | NSC-706744 | NSC706744 | NSC 706744 Hydrochloride | NSC 706744 | MJ-III65 Hydrochloride | MJ-III65 | LMP-744 hydrochloride | LMP744 hydrochloride | LMP-744 | LMP744 | LMP 744 Hydrochloride | LMP 744 | Inhibitor | inhibit |
| Inhibitors Related | Ciprofloxacin hydrochloride monohydrate | Berberine chloride | EIDD-1931 | Levofloxacin hydrochloride | Norfloxacin | Anthraquinone | Prulifloxacin | 1,4-Naphthoquinone | Ofloxacin | Levofloxacin | 3-Hydroxypyridine | Etoposide |
| Related Compound Libraries | DNA Damage & Repair Compound Library | Bioactive Compound Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | Inhibitor Library | Anti-Aging Compound Library | Clinical Compound Library | Bioactive Compounds Library Max | Anti-Cancer Compound Library | Anti-Cancer Drug Library | Anti-Cancer Active Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
-
CAS:54-71-7
-
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $2.00 |
VIP2Y
|
ZHENGZHOU JIUYI TIME NEW MATERIALS CO,.LTD
|
2026-07-02 | |
|
VIP4Y
|
Dingwang Technology (Wuhan) Co., Ltd.
|
2025-08-22 | ||
| $122.00 |
VIP6Y
|
TargetMol Chemicals Inc.
|
2026-07-06 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, USA
INQUIRY